LDLR and atherosclerosis: In an in vivo study, FO administration significantly reduced the aortic lesions and inflammation in the Ldlr−/− mouse model of atherosclerosis, but not in Ldlr−/−/Prkaa2−/−and Ldlr−/−/Prkaa2−/−Sm22Cre mice.